MPM Oncology Impact Management »

Mirum Pharmaceuticals shares owned by MPM Oncology Impact Management

Quarter-by-quarter ownership of Mirum Pharmaceuticals (MIRM) shares owned by MPM Oncology Impact Management from 13F filings

Historical chart of MPM Oncology Impact Management investment in Mirum Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Mirum Pharmaceuticals held by MPM Oncology Impact Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Mirum Pharmaceuticals by MPM Oncology Impact Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $17M 493k 34.19
2022-09-30 $2.0M 97k 21.01
2022-06-30 $5.6M 289k 19.46
2022-03-31 $6.4M 289k 22.02
2021-12-31 $4.8M 299k 15.95
2021-09-30 $6.1M 309k 19.92

More positions owned by MPM Oncology Impact Management

Cullinan Therapeutics Common (CGEM)
Insmed Incorporated Common (INSM)
Olema Pharmaceuticals Common (OLMA)
iTeos Therapeutics Common (ITOS)
Crinetics Pharmaceuticals Common (CRNX)
Madrigal Pharmaceuticals Common (MDGL)
Iovance Biotherapeutics Common (IOVA)
Natera Common (NTRA)
Mirum Pharmaceuticals Common (MIRM)
Ultragenyx Pharmaceutical Common (RARE)
Moonlake Immunotherapeutics Class A Ord (MLTX)
Guardant Health Common (GH)
Disc Medicine Common (IRON)
Alkermes Common (ALKS)
Edgewise Therapeutics Common (EWTX)

View all positions for MPM Oncology Impact Management

Top funds holding Mirum Pharmaceuticals

Frazier Life Sciences Management
Henderson Group
BVF
Eventide Asset Management
BlackRock
Vanguard Group
Cadian Capital Management
Rock Springs Capital Management
Citadel Advisors
Novo A/S
State Street Corporation
Tang Capital Management
T. Rowe Price Associates
First Turn Management
Pictet Asset Management Holding SA

View all funds holding Mirum Pharmaceuticals